ARMO Biosciences is a startup based in the United States, 2 tracked investors.
ARMO Biosciences is a startup based in the United States. Brouky records 2 investors associated with the company.
ARMO Biosciences develops next-generation cancer immunotherapies by engineering cytokine and immune cell therapies to enhance efficacy and safety in treating solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.